publicly traded companies glp-1 receptor agonist manufacturers Market Overview: Agonists and the Obesity Market | Blog Oral Non-Peptide GLP-1 Receptor Agonists
Description
GLP-1 medications are expensive, often exceeding $1,000 per month, and insurance coverage for off-label addiction use is uncertain
Subedi L, Bamjan AD, Phuyal S, Shim JH, Cho SS, Seo JB, et al
This mechanism is thought to be responsible for Retatrutides notable efficacy in resolving hepatic steatosis (fatty liver disease)
At the same time, the large number of obese patients preferred its use
The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care
Compounded semaglutide, where still available, runs $150-300 per month
